Hydrolysed Vegetable Protein Market Landscape Assessment By Type, Opportunities And Higher Mortality Rates By 2030

Consumers have become increasingly conscious about the environmental damages, which is attributable for the trend of shifting to a vegan protein diet which is more sustainable. Future Market Insights (FMI) in a new study sees this as one of the key factors enabling growth in the hydrolysed vegetable protein market, which is expected to surpass US$ 1.17 Bn by 2021. Hydrolysed vegetable protein has various health benefits which include improving digestion, lowering the rate of heart disease and enhancing the immune system. Such properties of hydrolysed vegetable protein products have been helping them gain traction among consumers who are willing to spend more products such as hydrolysed pea protein foods.

In the last five years, consumers’ preferences have been shifting towards vegetable protein. This also is considered an outcome of them becoming more conscious about their health which has led to rise in the demand for nutritional food products. Coupled with rising health awareness, some of the leading companies have been promoting hydrolysed vegetable protein products’ benefits towards controlling and preventing diseases commonly associated with obesity and cholesterol. Consequently, hydrolysed protein derived from soy, wheat, pea, rice, flax, and other vegetarian sources have been registering sales uptick. Of these, the demand for soy protein is significantly high. FMI has forecast it to account for over 39% of the total market in 2021.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4949

Key Takeaways from the hydrolysed vegetable protein Market Study

  • Hydrolysed vegetable protein market will showcase growth at a positive pace through 2031. It has been forecast to exhibit 5.3% Y-o-Y growth in 2021
  • In North America, the U.S. has emerged dominant, accounting for 80.8% share in 2021
  • UK will remain a key market, exhibiting 4.1% Y-o-Y growth in 2021
  • Germany and France to remain lucrative markets for hydrolysed vegetable protein in Europe
  • Healthy growth expected in Japan and South Korea, while dominance in East Asia is likely to remain with China

“Companies operating in the hydrolysed vegetable protein market has been keenly focusing on product development and differentiation to carve a niche amid their respective competitive industries and this will favor overall expansion of the market in the coming years,” said a lead analyst at FMI.

Product Development by Market Players to Spur Growth Opportunities

An increasing number of consumers across the world have been showing inclination towards vegan protein. This has been encouraging companies to invest in new product development based on hydrolysed vegetable protein. The rising demand for sustainable solutions has been paving way for innovation. Besides this, preference towards products with higher shelf-life has emerged as chief driver of innovations within the market. Resultantly, a slew of product launches has been recorded in the last few years, which are expected to aid the overall expansion.

For instance, in 2019, DuPont launched six new hydrolysed vegetable protein nuggets from its SUPRO and TRUPRO product range. These new products offer more protein and less sodium and are is suitable for the manufacturers of snacks, serials, nutrition bar and others. These hydrolysed vegetable protein products include SUPRO soy protein nuggets with cocoa range and TUPRO pea protein nuggets.

Who is winning?

A few of the leading players operating in the Hydrolysed vegetable protein market are Glanbia Plc., Cargill Inc., Kerry Group PLC, DuPont de Nemours, Inc., Tate & Lyle Plc., Fuji Oil Holdings, Inc., The Scoular Company, Wilmar International Limited, AMCO Proteins, Roquette Frères, Puris Proteins LLC, Burcon NutraScience Corporation, Axiom Foods, Inc., Ajinomoto Co., Inc., and others.

The hydrolysed vegetable protein based products market has witnessed rapid growth in the past few years. Surge in the demand for plant-based products has resulted in fierce competition among manufacturers, suppliers, retailers, and food brands. Due to increasing competition, players in the hydrolysed vegetable protein market are compelled to invest, innovate, and introduce new products.

This has resulted in the expansion of hydrolysed vegetable protein portfolio by some of the renowned market players. For instance, Kerry Company’s strategy is to target regions such as Asia, EMEA, and Latin America, for growth via expanding its production footprint and business development with key regional and local players.

To gain more insights into the market with a detailed table of content and figures, click here:  https://www.futuremarketinsights.com/toc/rep-gb-4949

Get Valuable Insights into hydrolysed vegetable protein market 

Future Market Insights, in its new offering, provides an unbiased analysis of the hydrolysed vegetable protein Market, presenting historical demand data (2015-2019) and forecast statistics for the period from 2020-2030. The study divulges compelling insights on the hydrolysed vegetable protein market based on Product Type (Soy Protein, Wheat Protein, Pea Protein, Rice Protein, Chia Protein, Flax Protein, and Corn Protein), By Form (Chunks, Slices, Flakes, and Granules), By End Users (Household, Commercial, and Industrial) and By Distribution Channel (Direct, Hypermarket/ Supermarket, Convenience Store, Traditional Grocery Retail, Online Retail.) across seven major regions.

 

Oryzenin Market- Notable Developments, Potential Players & Worldwide Opportunities 2022

Future Market Insights (FMI) has published a new report, which is titled, “Oryzenin Market: North America to Dominate the Global Oryzenin Market in Terms of Revenue: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022).” According to the report, oryzenin is a much better alternative as compared to barley, wheat, and rye as it does not lead to any kind of allergies or disorders such as the celiac disease and this is a key factor boosting its demand worldwide. Consumers seeking lactose free and gluten free source of protein are extensively demanding oryzenin, as it is safe and does not cause any disorders relating to digestion. As per FMI, the global oryzenin market will reach an evaluation of US$12 mn by 2022, expanding it robust CAGR of 7.3% between 2017 and 2022

Oryzenin does not cause any of these problems, unlike wheat or barley or rye, and hence it pushes the adoption of oryzenin. Moreover, the rising demand for rice proteins owing to functional properties has contributed towards the growth of the global oryzenin market.

Oryzenin is a type of glutelin/protein which is typically found in seeds of rice. Consumers who are looking for alternatives to non-allergen, lactose free as well as gluten free source of proteins, can look forward to oryzenin as a better alternative. Oryzenin does not cause any kind of disorders with respect to digestion.

Click the link to get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4906

The market for oryzenin is also expected to be boosted by the increasing incidences of gastrointestinal diseases, celiac disease, and irritable bowel syndrome. As the demand for rice protein is increasing on account of its functional properties, the demand for oryzenin will also grow. This is because oryzenin is a glutelin type which is found in the seeds of rice. Some of the other factors impacting the growth of this market include the low cost of producing rice proteins, high protein content, and high gelling properties. All these aforementioned factors are the reasons behind the extensive use of oryzenin in the food and beverage industry. The increasing health awareness, use as an enhancer for boosting nutritional value in food products, and growing use in sports nutrition will spur the growth of this market worldwide.

On the basis of geography, the global oryzenin​ market is segmented into Asia Pacific, Europe, North America, and the Rest of the World. Of these, it is estimated that North America will emerge as the most lucrative regional market for oryzenin and expand at a healthy CAGR of 9% between 2017 and 2022. By product type, it is estimated that the isolate segment will lead in the market and expand at a healthy 8.3% CAGR from 2017 to 2022. This segment is also estimated to gain the highest BPS by the end of the forecast period. The report also states that the concentrates segment will exhibit high growth potential in the years to come and exhibit a remarkable CAGR throughout the forecast period.

On the basis of form, the dry segment is witnessing high growth rate exhibiting an 8.8% CAGR from 2017 to 2022. The drive segment is estimated to gain the highest VPS by the end of the forecast period. On the other hand, the liquid segment holds high share in the market as compared to the dry segment and this trend is estimated to continue for the rest of the office period. On the basis of application, the bakery and confectionery segment has witnessed the highest growth rate for oryzenin, closely followed by the sports and nutrition segment. The sports and nutrition segment is estimated to gain high BPS in the years to come. In fact the sports and nutrition segment is not only leading currently but is estimated to continue to do so in terms of revenue through 2022.

The report profiles leading players within the global oryzenin market for the purpose of study. These players are Kerry Group PLC, Aidp Inc., Shenzhen Beike Biotechnology Co. Ltd., BENEO GmbH, Axiom Foods, Inc., Ribus, Inc., Golden Grain Group Limited, Rice bran Technologies, Inc., Bioway (Xi’An) Organic Ingredients Co., Ltd., and The Green Labs LLC.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-4906

Key Segments Covered

Region

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

Product Type

  • Isolates
  • Concentrates
  • Other Type

Application

  • Sports & Energy Nutrition
  • Beverages
  • Bakery & Confectionery
  • Meat Analogs & Extenders
  • Dairy Alternatives

Function

  • Emulsifying
  • Texturizing
  • Gelling
  • Others

Form

  • Dry
  • Liquid

Key Questions Answered in the Report

What is the size of Oryzenin market?

The oryzenin is valued at US$ 104 Bn in 2021 and this market is set to grow at 7.3% CAGR.

Which are the oryzenin market companies?

Key competitors in oryzenin market are Aidp Inc, BENEO GmbH, Axiom Foods Inc, Ribus, Inc, the Green Labs LLC and Bioway (Xi’An) and Organic Ingredients Co, Ltd.

 

Dairy Alternatives Market: Future Innovation Ways, Growth & Profit Analysis, Forecast By 2032

Predominantly driven by considerably high prevalence of lactose intolerance, dairy alternatives continue to witness healthy sales at a global level. Once a niche sector in food industry, dairy alternatives currently represent a US$ 16 Bn market and will possibly witness a strong CAGR during the period of projection, 2019 – 2029.

Dairy alternatives are plant-based foods and beverages that can be used as a healthier alternative to dairy products. Almond milk, soy milk, and rice milk are some of the most popular dairy alternatives around the world. Due to the inclusion of a number of critical vitamins and minerals in dairy products, dairy alternatives are considered to be healthy.

The demand for dairy alternatives is driven by concerns about hormones, pesticides, and antibiotics in the dairy products. The remnants of the aforementioned chemicals are said to be dangerous to consume, particularly by pregnant women. Hormones included in dairy products are thought to trigger and initiate endometrial, prostate, and breast cancer in humans.

Get | Download Sample Copy with Graphs & List of Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-4852

Key Takeaways – Dairy Alternatives Market Study

  • There is a wide variety of dairy alternatives manufactured from different sources such as soy, oats, almond, coconut, hemp, and flax. Dairy alternatives are offered in flavored and unflavored variants. This diverse range of options is expected to boost expansion of the market.
  • The consumption of unflavored or regular dairy alternatives is higher than that of the flavored variety. However, in the forecast period, the demand for flavored dairy alternatives is anticipated to increase.
  • Organic dairy alternatives are gaining traction, especially in developed countries. Organic food consumption is the highest in the U.S., followed by European Union which accounted for retail sales of 45.2 billion and 34.3 billion respectively, in the year 2017.
  • Shelf storage of dairy products poses as a big challenge for stakeholders due to fear of spoilage. Dairy alternatives manufacturers launched shelf-stable products with a higher shelf life, which made storage of dairy alternatives economical and easier. This is anticipated to boost sales.
  • Among retail outlets, specialty stores account for the highest share in sales of dairy alternatives.

Despite a great deal of opposition from dairy manufacturers, dairy alternatives market is expected to double in the forecast years. Nutrition, taste, easy availability of dairy alternatives, and consumer-centric approach are expected to contribute to this significant growth.

Millennials to Create Opportunity

The main consumers of dairy alternatives are millennials. Millennials show more concern towards animal welfare than any other generation as per consumer survey in 2018 by Comax Flavors, a flavor technology company for food and beverages. Additionally, as per the survey, health benefits are the main reason for which millennials consume dairy alternatives.

To retain and capture interest of millennials in an increasingly intense landscape, manufacturers are increasing their efforts in research and development. Almost all the companies in the dairy alternatives market, which are operating at a global level, are growing at exponential rates in terms of sale. Innovative ingredient and flavour combinations are responsible for the projected high growth rate of the dairy alternatives market.

The ongoing better-for-you and clean label trend is boosting market growth. Though the growth of dairy alternatives market is not expected to decline for the next 10-15 years, constant efforts in innovation and development of effective marketing strategies are a prerequisite for growth in future.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4852

Know More About Dairy Alternatives Market Report

Future Market Insights, in its new offering, offers an unbiased analysis of the global dairy alternatives market, presenting historical demand data (2014-2018) and forecast statistics for the period from 2019-2029. The study divulges compelling insights on the dairy alternatives market based on the source (soy, almond, rice, coconut, oats, and others), product type (flavoured and unflavoured), nature (organic and conventional), and distribution channel (direct and indirect) across seven major regions.

 

Non Fat Dry Milk Market – Growth, Statistics, By Application, Production, Revenue & Forecast To 2022

Non fat dry milk, better known as powdered milk have many benefits which has led to the growth of this market across the globe. The shelf life of nonfat dry milk is much more than that of liquid milk and this is also a primary reason, boosting its demand. In addition to this, non fat dry milk thickens food products. Future Market Insights (FMI) has published a new report, which is titled, “Non Fat Dry Milk Market: Asia-Pacific Excluding Japan (APEJ) to Dominate the Global Market in Terms of Revenue: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022). According to the report, the key factor bolstering the growth of this market is the extensive use of nonfat dry milk to prepare meat products, soups, cakes, puddings, as well as many confectioneries.

Organic Valley, a farmer owned dairy co-operative and organic food brand has produced a fat free variety of milk to its grass fed product line. The new fat free glass milk has been launched and supply has been started from January this year. As per the rising demand for non-fat 100% grass fed milk, the company’s line up for grass milk product has grown even further. The company is at the forefront of technologies such as installing robotics milkers, etc.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4853

Other benefits of non fat dry milk, which are boosting its demand include the fact that it is a cheap source of non fat dairy solids, can be easily transported without many precautions, a good source of functional dairy solids, and can be considered as a temporary replacement for whey proteins. Yet, there are a few drawbacks of using non fat dry milk, that have a negative impact on the growth of the global non nonfat dry milk market. Increasing prices of non fat milk, altering taste, and a loss of original richness are some of the factors that are expected to restrict the growth of this market. . These aspects are hindering the growth of the global nonfat dry milk market.

Non powdered milk is available both in the instant and non instant form. Soups, puddings, and cakes are some of the items in which this type of milk is used. Nonfat dry milk helps retain the thickness of a food item by its rich texture and thus, finds its use in cereals and milk beverages. As per the research report by FMI, the global nonfat dry milk market will reach the figure of US$7.9 bn by 2022 and expand steadily during the period from 2017 to 2022. On the basis of geography, the market is segmented into Asia Pacific except Japan or APEJ, Europe, North America, and the Rest of the World. Of these, it is estimated that the most lucrative market for non fat dry milk market will be APEJ. This region is slated to expand at a 3.8% CAGR from 2017 to 2022. Apart from APEJ, it is expected that North America will also show promising growth opportunities for the non fat dry milk market.

The high heat segment is predicted to lead in the global nonfat dry milk market, by product. This segment showed the highest market share in 2017, and this trend is expected to continue throughout the forecast period as this segment also shows the highest growth rate in the forecast period, that of 4.5% CAGR during the period of 2017 to 2022 and is also predicted to gain a high BPS by the end of 2022.

With respect to growth rate and market share, other retail formats segment also shows high potential. Also, in comparison to the modern trade segment, this segment shows a comparatively high growth rate. This segment is slated to have the highest BPS by the end of 2022 and is expanding at a CAGR of 3.6%.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4853

Key players within the global non fat dry milk market are profiled in this report for the purpose of study. The business and financial overview of these companies have also been analyzed in the report. Along with this, the information on the various expansion strategies adopted by leading players is given. Some of the key players operating in this market are: SunOpta, Inc., Blue Diamond Growers, Inc., Danone, OATLY A.B, Organic Valley Cropp Cooperative, Eden Foods Inc., The Hain Celestial Group, Inc., and Earth’s Own Food Company Inc.,

 

Textural Food Ingredients Market Size, Share, Future Road-map, Technological Innovations & Growth Forecast To 2027

The growing consumer demand for better texture and taste in food products consumed has forced food manufacturers to resort to product innovation in textural food ingredients to cater to a diversified consumer palate. Future Market Insights has recently published a new report titled “Textural Food Ingredients Market: Global Industry Analysis 2012- 2016 and Opportunity Assessment 2017-2027” that studies the global textural food ingredients market over a 10 year assessment period (2017 to 2027) and provides vital insights into the factors impacting revenue growth of the global and regional markets, along with detailed forecasts based on the market segmentation.

The textural food ingredient market is valued at nearly US$ 4 Bn in 2021. The market is expected to grow at a CAGR of 4.9% CAGR through 2027, reaching US$ 5.28 Bn by 2027.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4838

North America region is biggest market for textural food ingredient market and is estimated to hold 30% of the global share by 2027, which is US$ 5.2 Bn.

Western Europe is the second largest market for textural food ingredient market and is valued US$ 3.5 Bn, with a CAGR 5.3%.

Trends Observed in the Global Textural Food Ingredients Market

The analysis reveals some interesting trends in the demand for and consumption of textural food ingredients over the forecast period. A rise in multi-texture eating experiences has been noted across the key developing economies. Innovation in textural food ingredients has helped manufacturers reduce the cost of food products and there is an increasing adoption of the non-GMO hydrocolloid system. Developing nations are key opportunity areas for manufacturers operating in the global textural food ingredients market and there is an increasing focus on e-commerce and social media to reach a larger customer base. Digital media is fast emerging as a boon for key players in the global textural food ingredients market.

Global Textural Food Ingredients Market: Segmentation and Forecast

The global textural food ingredients market has been segmented on the basis of Functionality (Emulsifying Agent, Thickening Agent, Stabilising Agent, Gelling Agent, Others); Application (Dairy Products and Frozen Food, Bakery and Confectionery, Sauces, Dressings, and Condiments, Beverages, Snacks and Savoury, Meat and Poultry Products, Pet Food); Type (Hydrocolloids, Starch and Derivatives, Emulsifiers, Others); Form (Concentrate, Powders, Flakes); and Region (North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, MEA).

  • Hydrocolloids type segment will remain dominant throughout the forecast period with over 55% market share, followed by Emulsifiers at 29% value share
  • Stabilising Agent segment by functionality will lead in terms of market value, estimated to reach a valuation in excess of US$ 7,800 Mn by 2027 end
  • By application, the Dairy Products and Frozen Food segment will remain dominant with almost US$ 4,500 Mn in revenues by end 2027 and a CAGR of 5.5%
  • The Powder form segment will dominate the global market in terms of value share, estimated to hold more than 45% share of the market by 2027 end
  • North America region will dominate the global market for textural food ingredients, with almost 30% value share and revenues in excess of US$ 5,200 Mn by the end of the forecast period in 2027

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-4838

Global Textural Food Ingredients Market: Vendor Analysis

The report features some of the prominent players operating in the global textural food ingredients market such as Cargill, Incorporated, Kerry Group Plc., Dohler GmbH, Tate & Lyle PLC, Sensient Technologies Corporation, Archer Daniels Midland Company, Koninklijke DSM N.V., Ajinomoto Co., Inc., CHS Inc., Ingredients Inc., C.P. Kelco, Naturex SA, FMC Corporation, Ingredion Incorporated, E. I. du Pont de Nemours and Company, Foodchem International Corporation, Symrise AG, Ashland Global Holdings Inc., Furest Day Lawson Holdings Limited, Lonza Group Ltd. The global textural food ingredients market is highly fragmented; however, the market is more inclined towards technically superior and sophisticated products. Leading market players are targeting the growing economies in the APEJ region, owing to an increasing consumer preference for more variety in texture and taste in food products across various countries in the region.

 

Pharmaceutical Intermediates Market to grow at 4.3% CAGR through 2030

The rapidly increasing prevalence of chronic diseases around the world is expected to fuel the need for novel drugs and better treatment option would further drive the growth of the global market. Due to increasing demand for novel drugs option, there has been rising applications of drug intermediates and growing adoption and in the field of research and clinical studies.

Leading players in the biotechnology and pharmaceutical sectors along with research institutes are now increasingly focusing on R&D activities relating to drug creation and development. Future Market Insights (FMI) in a new study has forecast the global pharmaceutical intermediates to reach US$ 30 Bn in 2020, with the market predicted to exhibit a CAGR of 4% during the forecast period (2020-2030)

Pharmaceutical intermediates are used in during manufacturing of bulk drugs as raw materials. These are the material produced during the synthesis of an active pharmaceutical ingredient (API). However, pharmaceutical and biotech companies can make use of these drug intermediates for the purposes of research and development (R&D). Moreover, there are different forms of pharmaceutical intermediates available such as high quality pharmaceutical intermediates, moderate quality pharmaceutical intermediates and premium quality intermediates. The high-quality and premium pharmaceutical intermediates are mainly used for R&D activities.

COVID-19 pandemic is negatively impacting pharmaceutical intermediates sales due to supply chain disruptions caused due to extended period of lockdown. Nonetheless growth is expected to recover because an increasing number of pharma companies are engaging in research and development to find effective treatment and vaccination for COVID-19 virus.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4515

Key Takeaways from Pharmaceutical Intermediates Marker Study

  • The demand for chiral intermediates will continue rising through the forecast period
  • East Asia will dominate in the global pharmaceutical intermediates market. China is expected to emerge as the most lucrative market for pharmaceutical intermediates in the region.
  • Analgesics to remain primary application, expanding at Y-o-Y rate exceeding 6% through 2020
  • The demand for Generic Drug Intermediates is expected to be higher than Branded Drug Intermediates
  • Biotech and Pharma Companies will continue exhibiting high demand for pharmaceutical intermediates

“Rising drug development activities worldwide as well as increasing adaption of pharmaceutical intermediates as raw material are driving the growth of global Pharmaceutical Intermediates market” says the FMI Analyst

Acquisitions, Partnerships and expansion are key Strategic Focus of Pharmaceutical Intermediates Market Players

Leading players in the Pharmaceutical Intermediates market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

  • On April 2018, strategic collaboration between Porton Pharma Solutions, Ltd. And Codexis, Inc. to use Codexis’ biocatalyst technology within Porton’s global custom active pharmaceutical ingredients (API) and intermediate for manufacturing business.
  • On June 2017, BASF SE is expanding its production capacity at Texas site, whereas it is also constructing new Ibuprofen API facility in Ludwigshafen, Germany, which is expected to be functional in 2021.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4515

Key Participant Insights

The global market is set to expand its scope in the forecast period, due to rising prevalence of chronic disease globally and adoption of Pharmaceutical Intermediates at various stages of drug development by pharmaceutical manufacturers. In addition to this, cost effectiveness and rise in alternate methods for purification of oligonucleotide has augmented the sales of Pharmaceutical Intermediates.

The key market players covered by FMI include Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, Codexis, Lianhe Chemical Technology Co., Ltd, Sanofi S.A, Dishman Group And BASF SE, And Chemcon Speciality Chemicals Pvt. Ltd consolidating their positions through mergers, acquisitions and new product launches.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-4515

Pharmaceutical Intermediates Market – Key Segments

Product

  • Chemical Intermediates
  • Bulk Drug Intermediates
    • Chiral Intermediates
    • Achiral Intermediates
  • Custom Intermediates

Category

  • Branded Drug Intermediates
  • Generic Drug Intermediates

Application

  • Analgesics
  • Anti-inflammatory Drug
  • Cardiovascular Drugs
  • Anti-diabetic Drugs
  • Antimicrobial Drugs
  • Anti-cancer Drugs
  • Others

End User

  • Biotech and Pharma Companies
  • Research Laboratory
  • CMOs/CROs

Donor Egg IVF (In-Vitro Fertilization) Market is projected to grow at a robust CAGR of 7.7% between 2022 and 2028

Adoption of donor egg IVF treatment accounted for the approximate revenue of US$ 2 billion in 2021, which are likely to witness a healthy spike by 6.7% in 2022. Future Market Insights (FMI) recently presented a research study on the global donor egg IVF market, according to which a majority of overall adoption is registered at fertility clinics and IVF centers.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2499

A Majority of Patients Seek Donor Egg IVF Treatment at Fertility Clinics & IVF Centers

Donor egg IVF is a procedure in which technological and pharmacological manipulation is used to help and promote pregnancy, the procedure has gained significant ground globally, in recent years. Donor egg IVF has rapidly become one of the most sought after fertility treatment alternatives among the infertile population.

The study opines that fresh donor egg cycle has been preferred over frozen donor egg cycle, attributed to the associated high rates of pregnancy and successful births. Currently, nearly 70% of donor egg IVF treatment adoption is recorded at IVF centers and fertility clinics, and more than 70% of the times, the procedure is conducted by using fresh donor egg cycle.

In the fresh donor egg cycle, eggs are retrieved, following which they are fertilized immediately and directly transferred to the recipient’s womb (uterus). The birth rate and pregnancy rate by using fresh donor egg cycle are estimated to be more than 36% and 55%, respectively. On the flipside, the birth rate and pregnancy rate by using a frozen donor egg cycle are just about 24% and 39%, respectively. According to the report, enhanced pregnancy and birth rates will continue to advocate preference for fresh donor egg IVF over frozen.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-2499

The Rising Burden of Infertility Pushing Scope of Egg Donor IVF Adoption

As concluded by FMI’s analysis, with an increasing number of couples postponing first pregnancy that generally leads to higher prevalence of age-related infertility issues, it is highly likely that procedures such as in-vitro fertilization (IVF) and a step ahead, donor egg IVF, will continue to witness robust demand in years to come.

Research has proven that the number of women with ovaries that have untimely ceased to function has been on a considerable rise over the recent past, and thus, donor egg remains the only chance for them to conceive and lead a successful pregnancy period. The increasing infertility burden is complemented by a strong increase in the number of female egg donors, which has been cited as another important factor pushing prospects of donor egg IVF market.

Europe’s donor egg IVF market is expected to witness strong growth in forthcoming years, followed by North America, as a result of high inbound of infertile population opting for fertility treatment, across the region. Moreover, the expensive costs of donor egg IVF treatment and favorable government initiatives and reimbursements on the same are accounting for prominence of these regions in global donor egg IVF industry. The report also indicates that donor egg IVF market in Asia Pacific will demonstrate high growth potential through the coming years, as a considerably large patient pool is seeking fertility solutions.

A majority of European countries offer good service at a reasonable budget for donor egg IVF procedures and some countries, such as Brazil and Australia, reimburse 50% of the treatment cost for unsuccessful donor egg IVF procedures, or reimburse other expenses such as accommodation or out-of-pocket costs for egg donors.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-2499

Donor Egg IVF (in-vitro fertilization) Market by Category

By Cycle Type:

  • Fresh Donor Egg Cycle
  • Frozen Donor Egg Cycle

By End User:

  • Direct / Patient
  • Hospitals
  • Fertility Clinics & IVF Centres

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Disposable Spinal Instruments Market is poised to increase at a robust CAGR of 8.3% between 2022 and 2028

Healthcare-Associated Infections or Hospital-Acquired Infections (HAIs) are caused while receiving medical treatment in a hospital facility. HAIs are among the major challenges to the safety of patients, and can have severe public health implications. These infections are also capable of causing disability and sometimes death. The occurrence of HAIs is increasing at an alarming rate. According to WHO, the prevalence of these infections in developed countries varies from 3.5% to 12%. Developing countries are at a higher risk as the rate of infection is 3-20 times higher in developing countries as compared to high-income countries.

In the U.S., more than 15 Mn surgeries are performed annually. Between 2% and 5% of patients are estimated develop a surgical site infection, which is between 160,000 and 300,000 surgical site infections nationwide each year. Surgical site infections are among the most commonly occurring HAIs in the U.S., and are the most expensive to treat. Fortunately, the adoption of various disposable devices and kits has reduced the incidence of surgical site infections and HAIs.

Thus, the increasing preference for the usage of disposable instruments for reducing the occurrence of HAIs is driving the demand for disposable instruments, which is creating growth opportunities for the disposable spinal instruments market.

According to latest research by FMI, the global disposable spinal instruments market is estimated to have accounted for US$ 43.7 Mn in terms of value in 2021. The report on the disposable spinal instruments market further projects that the disposable spinal instruments market is likely to grow at a CAGR of 8.2% during the period 2022-2029.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6890

The demand for disposable instruments kits in the healthcare industry is growing at a significant rate, and the demand from unconventional end-use industries is one of the major factors fuelling the market for disposable spinal instruments. Growth in the number of end users, apart from hospitals, such as orthopaedic clinics and Ambulatory Surgical Centres (ASCs), is expected to create high demand for disposable spinal instruments. Moreover, the adoption of disposable instrument kits by various end users has reduced the risk of infections and cross-contamination, which has resulted in a reduction in the number of HAIs.

Increase in the number of use cases of disposable spinal instruments in hospitals and ASCs is expected to boost the global demand for disposable instrument kits. According to CDC, the number of Medicare-certified ASCs has increased steadily from 239 in 1983 to 5,316 in 2010.

Moreover, increasing geriatric population, which is prone to various types of spinal injuries, is estimated to boost the need for surgeries. This is expected to contribute to the demand for disposable spinal instruments. The increasing requirement of instrument kits during surgeries among the greying population, coupled with improved life expectancy, has created significant growth opportunities for the manufactures of disposable spinal instruments market. However, factors such as stringent regulations and the generation of a significant amount of waste due to the usage of disposable kits is expected to lower the growth of disposable spinal instruments in the forecast period.

The disposable spinal instruments kits segment is a leading segment in terms of revenue by product type in the disposable spinal instruments market, with a 64.5% revenue share in 2021. These kits are most widely used in cervical and lumbar surgeries such as spinal fusion and decompression surgeries. Among the procedure type segments, the spinal fusion sub-segment accounts for the largest revenue share in the disposable spinal instruments market. Among all the end users in the disposable spinal instruments market, the hospitals sub-segment is expected to be a prominent segment, followed by the orthopaedic clinics sub-segment.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-6890

The disposable spinal instruments market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America, followed by Europe, is a prominent region in the global disposable spinal instruments market. North America accounted for a revenue share of 45.8% in 2021 in disposable spinal instruments market. Europe, accounting for the second-largest revenue share, is followed by East Asia in the disposable spinal instruments market. India, China, and Brazil are emerging markets in the disposable spinal instruments market. China is one of the fastest-growing emerging markets in the global disposable spinal instruments market, and is projected to grow at a CAGR of 11.2% over the forecast period of 2022-2029.

The disposable spinal instruments market report tracks some of the key companies operating in the disposable spinal instruments market, such as ECA Medical, Providence Medical Technology, Inc., Xenco Medical, Paradigm Spine, Intelligent Implant Systems, LLC, Safe Orthopaedics, SA , TeDan Surgical Innovations, LLC, and Joimax GmbH. Majority of the regional players in the disposable spinal instruments market are focused on increasing their product reach and connectivity with the regional distributors of disposable spinal instruments. The manufacturers of disposable spinal instruments are focusing on collaborating with established hospitals and ASCs to sell products as some of the medical practitioners are particular about the type and brand of products used for a surgical procedure.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-6890

Disposable Spinal Instruments Market by Category

By Product Type :

  • Instrument Kits
  • Cervical
  • Lumbar
  • Systems
By Procedure:
  • Spinal Fusion
  • Decompression Surgeries
By End User:
  • Hospitals
  • Orthopaedic Clinics
  • Ambulatory Surgical Centers

Radiotherapy Patient Positioning Accessories Market will rise at 5.1% CAGR over the forecast period from 2022 to 2028

Estimated to exceed the revenues of US$ 588.8 million in 2022, the global market for radiotherapy patient positioning accessories is projected to witness a moderate 4.3% annual growth in revenue, over that in 2021. According to a recent research study of Future Market Insights (FMI), nearly 1/5th of the overall installed base of radiotherapy patient positioning accessories is accounted by couch tops and overlays, followed by immobilization systems.

More than 40% of the total adoption of radiotherapy patient positioning accessories is registered by hospitals at a global level, as indicated by FMI’s report. A higher rate of demand for radiotherapy patient positioning accessories is likely to be recorded by cancer research institutes and radiation therapy/proton therapy centers, in the forthcoming years.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9325

Government Support Pivotal in Accelerating Installation of Radiotherapy Patient Positioning Accessories

North America and Europe currently hold a combined revenue share of over 60% in the global radiotherapy patient positioning accessories market. Remarkable increase in the rate of early cancer diagnosis is leading to hike in the adoption of radiotherapy, more prominently in developed countries such as the US, UK, and Germany among others. Moreover, the study opines that the increasing awareness about multiple types of cancers, further backed by favorable government initiatives regarding cancer diagnosis and treatment, will be one of the strongest factors pushing penetration of radiotherapy patient positioning accessories within developed regional markets.

On the other side, governments of several developing economies are also extending support and investments in the cancer diagnosis and treatment space, particularly through screening camps – which is boosting the diagnosis rates of cancer. This according to the report is majorly responsible for promising growth in the installed base of radiotherapy systems and patient positioning accessories. According to FMI’s analysis, the flourishing medical tourism sector is also registering significant contribution to the thriving demand for radiotherapy patient positioning accessories in emerging economies.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9325

Strategic Efforts in Stronger Distribution Network Gathering Momentum among Manufacturers

Some of the key players actively competing in the radiotherapy patient positioning accessories market include Bionix Radiation Therapy, CDR Systems, CIVCO Radiation, Orfit Industries N.V., IZI Medical Products, Klarity Medical Products, Qfix, Elekta AB, and Eckert & Ziegler BEBIG, among others. Several leading manufactures are focused on the development and approval of new products. CIVCO Radiotherapy announced the FDA clearance and CE mark for their Solstice SRS Immobilisation System, in the H2 2021.

Strong distribution partnerships tend to result in effective product reach across the value chain and thereby supports the business growth. While the growing trend of strategic distribution partnerships between peer companies operating in the radiotherapy patient positioning accessories market is translating into improved product outreach, FMI’s analysis suggests that collaborative activities in terms of distribution of radiotherapy patient positioning accessories will particularly benefit smaller players in the market. Recently, POLL Medical entered the partnership with CIVCO for the global distribution of CE-marked GrayDuck Stents.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-9325

Radiotherapy Patient Positioning Accessories Market by Category

By Product Type

  • Couch Tops & Overlays
  • Immobilization System
  • Head Rest
  • Cushions
  • Spacers & Wedges
  • Arm & Wrist Supports
  • Thermoplastic Masks & Sheets
  • Locating & Indexing Bar
  • Bite Positioner
  • Markers

By End User

  • Hospitals
  • Radiation/Proton Therapy Centers
  • Cancer Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Electronic Stethoscope Market is expected to create an incremental opportunity worth US$ 170.9 Mn between 2022 and 2029

Up from nearly half a million units sold in 2018, the global sales of electronic stethoscopes will observe a robust 7.2% growth in 2022. The electronic stethoscopes market is expected to create an incremental opportunity worth US$ 170.9 Mn between 2022 and 2029.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9457

Key Manufacturers Continue to Strategize on New Product Launches in Electronic Stethoscopes Landscape

Almost 2/5th of total adoption of electronic stethoscopes is registered at hospitals, the report underscores that there has been significant adoption by medical institutes in the recent past. In the next few years, medical institutes and ambulatory surgical centers are likely to create multiple opportunities for manufacturers of electronic stethoscopes.

More than half of the overall sales is accounted by amplifying electronic stethoscopes, as indicated by FMI’s analysis. While amplifying electronic stethoscopes provide results as accurate as digitizing electronic stethoscopes, the latter are associated with high maintenance owing to the presence of multiple electronic components. Amplifying electronic stethoscopes are thus expected to observe significant growth in revenue over the course of coming years.

According to the report, the market attractiveness of amplifying stethoscopes is strongly backed by the increasing number of launches of new electronic stethoscopes by a number of small- and medium-sized companies. Electronic stethoscopes are rapidly replacing conventional variants across developed countries, predominantly owing to accelerated regulatory approvals.

  • eKuore had launched the first wireless stethoscope for medical use.
  • Eko had launched the first Android–connected digital stethoscope.
  • In April 2018, Steth IO launched a digital smartphone-enabled stethoscope.

According to the report, approximately 60% of the electronic stethoscopes that are sold are enabled with Bluetooth technology and an integrated chest piece system. The former is however poised to witness a higher rate of adoption over the coming years.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9457

North America Continues to Lead the Global Market for Electronic Stethoscopes

North America holds a considerable revenue share in the electronic stethoscopes market. With advancements in technology and the presence of a large number of healthcare facilities, electronic stethoscopes are being widely used in the region. Their ability to provide amplified sound output as well as reduce external sound makes it easy for medical professionals to detect sounds and provide proper treatment to patients.

FMI’s study has profiled some of the key companies operating in the global electronic stethoscopes market, including Eko Devices, eKuore, GlobalMed, 3M, Welch Allyn, Ambisea Technology Corp., Meditech Equipment Co., Ltd, HD Medical, Thinklabs, ADInstruments, and Cardionics Inc.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-9457

Electronic Stethoscope Market by Category

Product:

  • Amplifying Stethoscopes
  • Digitizing Stethoscopes

End User:

  • Hospitals
  • Clinics
  • Medical Institutes
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Medical Camps
  • Catheterization Laboratories

Application:

  • Integrated Chest-Piece System
  • Wireless Transmission System (Bluetooth)
  • Integrated Receiver Head-Piece System
  • Other

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA